For years, Biologic Pharmamedical has been steadfast in its commitment to scientific excellence, patent security, and the highest quality control in nutraceutical innovation. Our business model has ...

Reducing glucocorticoid use in the treatment of giant cell arteritis and polymyalgia rheumatica — due to the steroid’s host ...

Scientists modify the genes of bacteria and cells in a lab and use those living organisms to make biologic drugs. The FDA has approved these four biologics to treat atopic dermatitis: dupilumab ...

BioLogic Pharma Solutions aims to be the trusted partner for companies handling complex drug development and commercialization pathways.

In recent years, there's been a revolution in Disease-Modifying Antirheumatic Drugs, known as DMARDs, available to control RA, driven largely by biologic therapies. What are these agents ...

The TSXV serves as a vital platform for early-stage, high-growth companies, providing access to capital and a strong investor network. In 2024, 80% of the TSXV Venture 50™ companies operated ...

Thus, it turns out that both sides in an earlier debate about biosimilars' impact on the biologic drug market were correct. In 2017, at the American College of Rheumatology's annual meeting ...

Biologic medicines have transformed treatment for numerous chronic and life-threatening conditions such as cancer, ...

“We are enthusiastic about getting patients started in the OCU200 Phase 1 clinical trial and sharing not only safety but preliminary efficacy data as the study progresses,” said Dr. Huma Qamar, Chief ...